We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

2 hedge funds and large institutions have $0 invested in Sanofi Contingent Value Rights in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 103 → 2 (-101)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $140M → $0 (-$140M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 98

Holders
2
Holders Change
-101
Holders Change %
-98.06%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
98
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
-$46.8M
2
MCM
Mason Capital Management
New York
-$12.6M
3
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$11.4M
4
BCM
Brigade Capital Management
New York
-$11M
5
FCM
Farallon Capital Management
California
-$7.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
YCM
26
Yakira Capital Management
Connecticut
– -$133K -155,177 Closed
JC
27
JBF Capital
Colorado
– -$114K -132,702 Closed
UBS Group
28
UBS Group
Switzerland
– -$78K -91,084 Closed
GI
29
GAMCO Investors
Connecticut
– -$54K -62,400 Closed
ZIG
30
Zuckerman Investment Group
Illinois
– -$36K -41,483 Closed
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
– -$35K -41,260 Closed
Royal London Asset Management
32
Royal London Asset Management
United Kingdom
– -$36K -41,192 Closed
Citadel Advisors
33
Citadel Advisors
Florida
– -$26K -30,684 Closed
Bank of America
34
Bank of America
North Carolina
– -$23K -26,509 Closed
Ameriprise
35
Ameriprise
Minnesota
– -$16K -19,209 Closed
LPL Financial
36
LPL Financial
California
– -$14K -16,311 Closed
MC
37
Moors & Cabot
Massachusetts
– -$14K -16,000 Closed
HKAM
38
Horizon Kinetics Asset Management
New York
– -$14K -15,940 Closed
CHAM
39
Clear Harbor Asset Management
Connecticut
– -$13.4K -15,635 Closed
RWP
40
RWA Wealth Partners
Massachusetts
– -$13K -15,000 Closed
William Blair & Company
41
William Blair & Company
Illinois
– -$12K -14,032 Closed
EAM
42
Erste Asset Management
Austria
– -$10.3K -12,000 Closed
BlackRock
43
BlackRock
New York
– -$10K -11,392 Closed
BIA
44
Biondo Investment Advisors
Pennsylvania
– -$9K -10,800 Closed
DA
45
Dillon & Associates
Michigan
– -$9K -10,260 Closed
Morgan Stanley
46
Morgan Stanley
New York
– -$8K -9,412 Closed
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
– -$6K -8,154 Closed
Deutsche Bank
48
Deutsche Bank
Germany
– -$6K -8,000 Closed
Wells Fargo
49
Wells Fargo
California
– -$7K -7,985 Closed
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
– -$5K -6,310 Closed
1
2
3

GCVRZ Hedge Fund Activity: Q1 2020 in Review

2 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2020, worth a combined $0 — down 100% from $140M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of GCVRZ and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Stonehill Capital Management, exiting entirely with an estimated $46.8M sold.

  • 2 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2020, down from 103 in Q4 2019.
  • Funds reported $0 of Sanofi Contingent Value Rights stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Sanofi Contingent Value Rights positions in Q1 2020 and 98 closed out, a net change of -98 holders.
  • The largest Sanofi Contingent Value Rights seller in Q1 2020 was Stonehill Capital Management, an estimated $46.8M sold.

Based on aggregated 13F filings for Q1 2020.